Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.755 USD | -2.30% | -2.81% | -32.27% |
05-13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
05-10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.27% | 374M | |
+60.88% | 62.59B | |
-2.21% | 41.18B | |
+44.42% | 40.29B | |
-8.29% | 27.9B | |
+12.76% | 26.21B | |
-21.44% | 19.09B | |
+5.61% | 13.08B | |
+24.52% | 12.26B | |
+27.91% | 12.05B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Transcript : Organogenesis Holdings Inc., Q4 2021 Earnings Call, Mar 01, 2022